Isn't it odd that we've received patents for Singapore and Canada but have supposedly been turned down by the US, per # 28050? Is this an anomaly? Canadian medicine and science are considered top rate and Canadian patent examiners are certainly on a par with US counterparts. Something is off here...and I hope that the company responds publicly ASAP.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.